Vacuum device shows promise for clot removal in 500-Patient study
NCT ID NCT06446024
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested the INDIGO Aspiration System, a device that uses a vacuum to remove blood clots from arteries and veins. It included 500 patients in Japan with acute limb ischemia, mesenteric artery occlusion, or severe deep vein thrombosis. The goal was to confirm the device's safety and effectiveness in real-world use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
INDIGO Aspiration System (a device that uses vacuum to remove blood clots from blood vessels)
What this could lead to
If successful, this could confirm that the INDIGO system is a safe and effective tool for quickly removing dangerous blood clots, potentially reducing the need for more invasive surgery.
What could go wrong
This is a post-market study, meaning the device is already approved. However, results may not apply to all patients, and risks like bleeding or clot re-formation remain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LIMB ISCHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nara City Hospital
Nara, 630-8305, Japan